Key result
7-day Holter detects new-onset AF in ~5% of patients with prior ischemic stroke.
Why the study?
The diagnostic benefit of continuous ECG for poststroke AF screening in a primary care setting is unclear.
Does 7-day Holter monitoring improve the detection of atrial fibrillation compared to pulse palpation and 12-lead ECG in primary care patients more than 1 year post-ischaemic stroke?
Cohort (n=366)
Yes
Does 7-day Holter monitoring improve the detection of atrial fibrillation compared to pulse palpation and 12-lead ECG in primary care patients more than 1 year post-ischaemic stroke?
Number Needed to Treat: 22 (95% CI 14–37)
Absolute Event Rate: 4.6% vs 0.82%
Number Needed to Treat: 22
In primary care patients more than 1 year post-ischaemic stroke, 7-day Holter monitoring significantly improves the detection of silent atrial fibrillation compared to standard pulse palpation and 12-lead ECG.
Supports prolonged AF screening in remote post-stroke patients; leaves open whether detection improves outcomes before practice change.
BACKGROUND AND PURPOSE: The diagnostic benefit of using continuous ECG (cECG) for poststroke atrial fibrillation (AF) screening in a primary care setting is unclear. We aimed to assess the diagnostic yield from screening patients who previously had a stroke with a 7-day Holter monitor. METHODS: Patients older than 49 years, naive to AF, with an ischaemic stroke over 1 year before enrolment were included. In a primary care setting, all patients were screened for AF using pulse palpation, 12-lead ECG and 7-day Holter monitoring. Further, NT-proBNP was determined at baseline. RESULTS: 7-day Holter monitoring uncovered AF in 17 of 366 patients (4.6% (95% CI 2.7 to 7.3)). The number needed to screen was 22 patients (14-37). 12-lead ECG uncovered AF in 3 patients (0.82% (95% CI 0.17 to 2.4)), and 122 patients had irregular pulse during pulse palpation (33.5% (95% CI 28.7 to 38.2)). When using 7-day Holter monitoring as reference standard, the sensitivity of pulse palpation and 12-lead ECG was 47% (95% CI 23% to 72%) and 18% (95% CI 4% to 43%). High levels (≥400 pg/mL) of NT-proBNP versus low levels (≤200 pg/mL) were not associated with AF in the univariate analysis nor when adjusted for age (OR 2.4 (95% CI 0.5 to 8.4) and 1.6 (95% CI 0.3 to 6.0)). CONCLUSIONS: A relevant proportion of patients with stroke more than 1 year before inclusion were diagnosed with AF through 7-day Holter monitoring. Given the low sensitivities of pulse palpation and 12-lead ECG, additional cECG may be considered during poststroke primary care follow-up.
No takes yet. Share an insight, caveat, or question.
Lyckhage et al. (2020) conducted a cohort in Ischemic stroke (n=366). 7-day Holter monitoring vs. 12-lead ECG and pulse palpation was evaluated on Proportion of newly diagnosed atrial fibrillation (NNT 22, 95% CI 14-37). 7-day Holter monitoring uncovered new-onset atrial fibrillation in 4.6% of patients with a history of ischemic stroke over 1 year prior, with a number needed to screen of 22.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: